Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing

Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing

Source: 
Reuters
snippet: 

Obesity drug-maker Novo Nordisk (NOVOb.CO) will spend $4.1 billion to build a U.S. facility to fill injection pens for its hugely popular weight-loss treatment Wegovy and diabetes drug Ozempic, it said on Monday.